Anesthetic Management of Whole-Lung Lavage Using Propofol-Remifentanil in a Patient with Pulmonary Alveolar Proteinosis.
10.4266/kjccm.2012.27.3.173
- Author:
Ji Hyeon LEE
1
;
Chan Jong CHUNG
;
Ji Na OH
;
Byung Ju KO
;
So Ron CHOI
Author Information
1. Department of Anesthesiology and Pain Medicine, College of Medicine, Dong-A University, Busan, Korea. cjchung@dau.ac.kr
- Publication Type:Case Report
- Keywords:
hypoxic pulmonary vasoconstriction;
propofol-remifentanil;
pulmonary alveolar proteinosis;
whole-lung lavage
- MeSH:
Humans;
One-Lung Ventilation;
Phospholipids;
Proteins;
Pulmonary Alveolar Proteinosis;
Therapeutic Irrigation;
Vasoconstriction
- From:The Korean Journal of Critical Care Medicine
2012;27(3):173-178
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pulmonary alveolar proteinosis (PAP) is characterized by the progressive accumulation of phospholipids and proteins within the alveolar sacs without producing an inflammatory response. Whole-lung lavage (WLL) is performed as the standard therapy for this disease because it serves to wash out the proteinaceous material from the alveoli. In this case, we performed sequential WLL using propofol-remifentanil, which is not related to hypoxic pulmonary vasoconstriction during one-lung ventilation. The patient's symptoms and radiologic findings showed improvement without the occurrence of any specific complications. Therefore, we report a case of anesthetic management of WLL performed repeatedly for a patient with recurrent PAP.
